ASHINGTON — It’s the literary equivalent of a campaign contribution: a well-placed op-ed piece, endorsing an agency nominee awaiting Senate confirmation. It’s How Washington Works. But few contenders have racked up the sheer number of public tributes as Scott Gottlieb, President Trump’s choice for FDA commissioner, who was confirmed by a Senate vote Tuesday.

Drug company lobbyists, academics with health industry funding, and a flurry of former colleagues have all picked up their pens on behalf of Gottlieb, the 44-year-old physician and former FDA deputy commissioner.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.